Risk of urinary tract infection after detrusor botulinum toxin A injections for refractory neurogenic detrusor overactivity in patients with no antibiotic treatment. [electronic resource]
- BJU international Apr 2011
- 1165; author reply 1165 p. digital
Publication Type: Comment; Letter
1464-410X
10.1111/j.1464-410X.2011.10216.x doi
Antibiotic Prophylaxis Botulinum Toxins, Type A--therapeutic use Humans Injections, Intramuscular Neuromuscular Agents--therapeutic use Recurrence Risk Factors Treatment Outcome Urinary Bladder, Neurogenic--drug therapy Urinary Bladder, Overactive--drug therapy Urinary Tract Infections--prevention & control